Wed, Apr 16, 2014, 2:36 PM EDT - U.S. Markets close in 1 hr 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • scanit2008 scanit2008 Apr 2, 2013 1:58 AM Flag

    E-Mail From the Company's C.E.O.

    The following post was posted on IHub this evening by Lewsogge:

    Email exchange with Gerald about latest 8k

    Gerald,

    I'm sure you're inbox and phone lines are being blown up right now, so I'll keep this brief. The increase in the O/S from ~225 million to 367 million is creating quite the stir amongst our investment group. With this new share structure AMBS' market cap is still only roughly $20,000,000 which I still consider severely undervalued. However, the unexpected increase in outstanding shares, as I'm sure you are well aware, will most likely damage the fragile relationship between yourself and cautious penny land traders who are no strangers to deceptions.

    I still believe in you and the company, and understand that a start up biotech will face tough times which can require tough decisions, such as dilution. I'm sure you have a precise plan on how to best handle this and look forward to seeing it play out. May you disclose why the move to Nevada? I thought Delaware was chosen for tax purposes, or am I confusing the states?

    Bests,

    Lewis

    Gerald Commissiong
    8:57 PM (1 minute ago)

    to lew
    Hi Lewis,

    Actually not too much from other shareholders thus far. As far as the
    increase, everything that we have stated is correct. We haven't
    entered into financing agreements since the last Q. What has happened
    specifically regarding the increase in O/S will be disclosed in our
    10K filing, which will be filed in the near future as we finalize a
    number of things that are meant to build value in the near-term.

    While the dilution was indeed significant, what it bought the
    shareholders was a much stronger company with much better prospects
    for future growth, additional product lines in our diagnostics
    platform and an entity that people with high repute and who are
    recognized in the field are happy to be associated with. I think the
    future is extremely bright from here, and agree entirely with you that
    we are substantially undervalued.

    Best Regards,
    Gerald

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMBS
0.07-0.01(-7.28%)2:18 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.